Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ACIU
#6081
AC Immune SA
2.9
3
-0.34%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.34%
Monthly Change
-17.93%
6 month change
+42.23%
Year Change
+14.45%
Previous Close
2.9
4
Open
2.9
3
Bid
Ask
Low
2.9
3
High
2.9
3
Volume
17
Markets
US Stock Market
Healthcare
ACIU
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
Total assets
—
—
—
—
—
Total liabilities
—
—
—
—
—
Total equity
—
—
—
—
—
Total liabilities & shareholders' equities
—
—
—
—
—
Total debt
—
—
—
—
—
Net debt
—
—
—
—
—
News
AC Immune启动脑渗透性NLRP3抑制剂1期临床试验
AC Immune begins phase 1 trial of brain-penetrant NLRP3 inhibitor
2026 Market Outlook: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD
Tesla and Rivian among market cap stock movers on Friday
AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's - AC Immune (NASDAQ:ACIU)
AC Immune股价在帕金森病试验数据积极后上涨
AC Immune stock rises after positive Parkinson’s disease trial data
AC Immune’s Parkinson’s treatment shows promise in slowing disease
AC Immune (ACIU) Reports Q3 Loss, Lags Revenue Estimates
Alector (ALEC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Earnings Preview: AC Immune (ACIU) Q3 Earnings Expected to Decline